Dr. Martens revenues for the 13 weeks to 29 December rose by 3 per cent in constant currency to reach £267m. The business has been working to revive its US DTC business whilst facing a tough European market. However, it is making good progress in the APAC region with its DTC offering.
New CEO Ije Nwokorie said: “Our Q3 trading was as expected, and our outlook for FY25 remains unchanged. We have made good progress against our objective of turning around our US performance, with USA DTC in positive growth in Q3.”
Share